Annular oligomeric amyloid intermediates observed by in situ atomic force microscopy

被引:75
作者
Zhu, M
Han, SB
Zhou, FM
Carter, SA
Fink, AL [1 ]
机构
[1] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
[2] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA
[3] Calif State Univ Los Angeles, Dept Chem, Los Angeles, CA 90032 USA
关键词
D O I
10.1074/jbc.M400004200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloidoses and related protein deposition diseases involve the transformation of normally soluble proteins into insoluble deposits, usually fibrillar in nature. Although it was originally assumed that the fibrils were the toxic species, this assumption has recently been called into question. Accumulating evidence in several systems suggests that oligomeric intermediates on the aggregation pathway may be toxic. In the present study we used in situ atomic force microscopy to monitor aggregation in aqueous solution in real time. The sample used was an amyloidogenic immunoglobulin light chain, involved in AL or light chain amyloidosis. The nature of the observed oligomeric intermediates was dependent on the conditions of incubation, especially pH and ionic strength. Several different aggregation intermediates with a variety of morphologies, including annular or torus-shaped species, were observed. The data indicate that protein aggregation can be very complex, involving a variety of different oligomeric intermediates whose population will be determined by the kinetic and thermodynamic competition between them.
引用
收藏
页码:24452 / 24459
页数:8
相关论文
共 37 条
[21]   THIOFLAVINE-T INTERACTION WITH SYNTHETIC ALZHEIMERS-DISEASE BETA-AMYLOID PEPTIDES - DETECTION OF AMYLOID AGGREGATION IN SOLUTION [J].
LEVINE, H .
PROTEIN SCIENCE, 1993, 2 (03) :404-410
[22]  
Lin MX, 1997, J BIOL CHEM, V272, P44
[23]   Pore formation by the cytotoxic islet amyloid peptide amylin [J].
Mirzabekov, TA ;
Lin, MC ;
Kagan, BL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :1988-1992
[24]   Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse α-synuclein [J].
Rochet, JC ;
Conway, KA ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (35) :10619-10626
[25]   Review: History of the amyloid fibril [J].
Sipe, JD ;
Cohen, AS .
JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) :88-98
[26]  
SOLOMON A, 1985, METHOD ENZYMOL, V116, P101
[27]   α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies [J].
Spillantini, MG ;
Crowther, RA ;
Jakes, R ;
Hasegawa, M ;
Goedert, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6469-6473
[28]  
Stevens F J, 1995, Methods Mol Biol, V51, P51
[29]   A MOLECULAR-MODEL FOR SELF-ASSEMBLY OF AMYLOID FIBRILS - IMMUNOGLOBULIN LIGHT-CHAINS [J].
STEVENS, FJ ;
MYATT, EA ;
CHANG, CH ;
WESTHOLM, FA ;
EULITZ, M ;
WEISS, DT ;
MURPHY, C ;
SOLOMON, A ;
SCHIFFER, M .
BIOCHEMISTRY, 1995, 34 (34) :10697-10702
[30]  
STEVENS PW, 1995, PROTEIN SCI, V4, P421